| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 04/08/2008 | US7354925 Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as ORL1-receptor antagonists |
| 04/08/2008 | US7354924 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| 04/08/2008 | US7354922 Bridged ring NK1 antagonists |
| 04/08/2008 | US7354918 cerebral oxygenators and vasoregulators; antidepressant, cognition activator; sleep disorders; enantiomer mixture separated by HPLC; classical antidepressants resistance |
| 04/08/2008 | CA2232663C At1-receptor antagonists for preventing and treating postischemic renal failure and for protecting ischemic kidneys |
| 04/03/2008 | WO2008039642A2 Methods and compounds for treatment of clostridium based infection |
| 04/03/2008 | WO2008039641A2 Substituted phenylether-thienopyridone compounds with antibacterial activity |
| 04/03/2008 | WO2008039640A2 Enantiomeric compounds with antibacterial activity |
| 04/03/2008 | WO2008039639A2 Substituted thienopyridone compounds with antibacterial activity |
| 04/03/2008 | WO2008038841A1 Thiadiazolone derivative and use thereof |
| 04/03/2008 | WO2008038768A1 Compound having bicyclic pyrimidine structure and pharmaceutical composition comprising the compound |
| 04/03/2008 | WO2008038251A2 3-aza-bicyclo[3.1.0]hexane derivatives |
| 04/03/2008 | WO2008037881A2 Derivatives of pyrrolizine, indolizine and quinolizine, preparation thereof and therapeutic use thereof |
| 04/03/2008 | WO2008037783A1 Process for preparing 2-oxo-2,5-dihydro-1h-pyrido[3,2-b]indole-3-carbonitriles |
| 04/03/2008 | WO2008037011A1 Polycyclic agents for the treatment of respiratory syncytial virus infections |
| 04/03/2008 | WO2008019363A3 2-alkylbenzoxazole carboxamides as 5ht3 modulators |
| 04/03/2008 | WO2008014291A3 Compounds and compositions as hedgehog signaling pathway modulators |
| 04/03/2008 | WO2008012622A3 Azabenzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor |
| 04/03/2008 | WO2007146375A3 Highly soluble pyrimido-dione-quinoline compounds and their use in the treatment of cancer |
| 04/03/2008 | WO2007145349A3 Substituted pyrrole derivatives |
| 04/03/2008 | WO2007117704A3 Pure isomers of tritoqualine |
| 04/03/2008 | WO2007109748A3 Foaming agents containing fluorine substituted unsaturated olefins |
| 04/03/2008 | US20080081825 5-((2,4-difluorophenyl) {[(1-methyl-4-piperidinyl)oxy]imino}methyl)-1-(2,6-dimethylphenyl)-2(1H)-pyridinone; p38 MAP kinase and tumor necrosis factor inhibitor; inflammatory cytokines or chemokine, respiratory diseases, cardiovascular diseases and bone diseases |
| 04/03/2008 | US20080081821 AZA-benzothiophenyl compounds and methods of use |
| 04/03/2008 | US20080081808 N-{4-[4-(2-{3-[(dimethylamino)methyl]phenyl}-1H-pyrrolo[2,3-b]pyridin-4-yl)-1-ethyl-1H-pyrazol-3-yl]phenyl}-N'-phenylurea; antitumor and anticarcinogenic agent; G2 and mitotic phases in cycling cells; solid tumor and hematological cancers |
| 04/03/2008 | US20080081807 Arylphenyl-substituted cyclic keto-enols |
| 04/03/2008 | US20080081803 Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity |
| 04/03/2008 | CA2664588A1 Enantiomeric fused-pyridinone compounds with antibacterial activity |
| 04/03/2008 | CA2664376A1 Polycyclic agents for the treatment of respiratory syncytial virus infections |
| 04/03/2008 | CA2663080A1 Derivatives of pyrrolizine, indolizine and quinolizine, preparation thereof and therapeutic use thereof |
| 04/03/2008 | CA2662612A1 3-aza-bicyclo[3.1.0]hexane derivatives |
| 04/02/2008 | EP1904495A2 Muscarinic receptor antagonists |
| 04/02/2008 | EP1904494A1 Imidazo[1,2-a]pyridine compounds as vegf-r2 inhibitors |
| 04/02/2008 | EP1904492A1 Method for obtaining a pharmaceutically active compound, synthesis intermediates thereof and methods for obtaining them |
| 04/02/2008 | EP1904482A2 Indolylmaleimide derivatives |
| 04/02/2008 | EP1904477A1 Indol-3-carbonyl-spiro-piperidine derivatives as v1a receptor antagonists |
| 04/02/2008 | EP1904461A2 Cyclic anilinopyridinotriazines as gsk-3 inhibitors |
| 04/02/2008 | EP1904452A2 Histone deacetylase inhibitors |
| 04/02/2008 | EP1904446A2 Azabicyclo derivatives as muscarinic receptor antagonists |
| 04/02/2008 | EP1697384B1 Pyrido- and pyrimidopyrimidine derivatives as anti-proliferative agents |
| 04/02/2008 | EP1575949B1 Fungicides |
| 04/02/2008 | EP1453506B1 Topoisomerase poison agents |
| 04/02/2008 | CN101155813A 1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine ethanesulfonate and 1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine methanesulfonate |
| 04/02/2008 | CN101155812A Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases |
| 04/02/2008 | CN101155811A Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases |
| 04/02/2008 | CN101155810A Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases |
| 04/02/2008 | CN101155809A Preparation of tadalafil intermediates |
| 04/02/2008 | CN101155808A Substituted 1,5-naphthyridine azolidinones as cdk inhibitors |
| 04/02/2008 | CN101155785A Novel adenosine a3 receptor modulators |
| 04/02/2008 | CN100378101C 1.3.4-triaza-phenalene and 1,3,4,6-tetraazaphenalene derivatives |
| 04/02/2008 | CN100378097C Methyl indoles and methyl pyrrolopyridines as alph-1 adrenergic agonists |
| 04/02/2008 | CN100378094C Novel 2-pyridinecarboxamide derivatives |
| 04/01/2008 | US7351838 First reactive functional group used to provide attachment to a surface of a substrate, second reactive functional group is a N-sulfonyldicarboximide group reacted with an amine-containing material, to form a connector group between the substrate and amine containing material (protein, peptide, dna rna) |
| 04/01/2008 | US7351831 Process for asymmetric intramolecular [3+2] cyclo-addition of hydrazones |
| 04/01/2008 | US7351825 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) (MMP) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis |
| 04/01/2008 | US7351713 Spirohydantoin compounds and methods for the modulation of chemokine receptor activity |
| 04/01/2008 | US7351711 Tricyclic indanyls as integrin inhibitors |
| 04/01/2008 | US7351707 Spiroazacyclic compounds as monoamine receptor modulators |
| 04/01/2008 | US7351700 4-(2-Hexylsulfanyl-6-methyl-pyrimidin-4-ylmethyl)-morpholine; antidepressant, anxiolytic agent, cognition activator; epilepsy, schizophrenia, spasticity and skeletal muscle rigidity, spinal cord injury, multiple sclerosis, amyotrophic lateral sclerosis, neuropathic pain |
| 04/01/2008 | US7351531 Molecules capable of binding to telomere and the like and method with the use of the same |
| 04/01/2008 | CA2432578C Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists |
| 03/27/2008 | WO2008036201A1 Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety |
| 03/27/2008 | WO2008036046A1 IMIDAZO[l,2-a]PYRIDINE HYDROXYMATE COMPOUNDS THAT ARE INHIBITORS OF HISTONE DEACETYLASE |
| 03/27/2008 | WO2008036022A1 Tetrahydro-lh-pyrido[3,4-b] indole derivatives as cb1 receptor ligands |
| 03/27/2008 | WO2008036021A1 Tetrahydro-lh-pyrido [3,4 -b] indole derivatives as cbl receptor ligands |
| 03/27/2008 | WO2008035686A1 Agent for improving insulin resistance |
| 03/27/2008 | WO2008034974A1 2-ARYL-6-PHENYLIMIDAZO[1,2-α]PYRIDINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF |
| 03/27/2008 | WO2008034882A1 Fluorinated catharanthine derivatives, their preparation and their utilisation as vinca dimeric alkaloid precursors |
| 03/27/2008 | WO2008034860A1 Pyrrolo[2, 3-b]pyridin-4-yl-benzenesulfonamide compounds as ikk2 inhibitors |
| 03/27/2008 | WO2008011560A3 Benzothiophene inhibitors of rho kinase |
| 03/27/2008 | WO2008008431A3 Heteroaryl sulfonamides and ccr2/ccr9 |
| 03/27/2008 | WO2008000469A3 Nicotinic agonists selective for the alpha7 receptor subtype, the process for the preparation thereof and pharmaceutical compositions therefrom |
| 03/27/2008 | WO2007135538A3 Reversion of malignant phenotype with 9-hydroxy ellipticine derivatives |
| 03/27/2008 | WO2007124345A3 Beta-amyloid pet imaging agents |
| 03/27/2008 | WO2007117381A9 2 -aminopyridine analogs as glucokinase activators |
| 03/27/2008 | WO2007109334B1 Sip receptor modulating compounds and use thereof |
| 03/27/2008 | US20080076943 4-(Hydroxymethyl)-2,6-dimethoxyphenylboronic acid chemical intermediate for preparing corticotropin-releasing factor receptor antagonists |
| 03/27/2008 | US20080076924 P2X7 purinergic receptor; pain, arthritis, autoimmune diseases, neurodegenerative diseases; N-aminothiocarbonyl-piperazines, N-aminocarbonylpiperazines, or cyanoguanidine-functional piperazines |
| 03/27/2008 | US20080076794 Hyperaldosteronism |
| 03/27/2008 | US20080076784 Bicyclic, Nitrogen-Containing Heterocycles and Aromatase Inhibitors |
| 03/27/2008 | US20080076773 Such as (3R,4R)-1-Pyrimidin-4-yl-4-(2,4,5-trifluorophenyl)piperidin-3-amine bis-trifluoroacetic acid salt |
| 03/27/2008 | US20080076763 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol; 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(2S)-2-morpholinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol for treating cancer and arthritis |
| 03/27/2008 | US20080076754 Substituted spiroheterocycles |
| 03/27/2008 | US20080076753 Substituted spiroheterocycles |
| 03/27/2008 | US20080076751 Azetidinone Derivatives and Methods of Use Thereof |
| 03/27/2008 | US20080076738 antiviral: improved pharmacokinetics |
| 03/27/2008 | US20080076188 Luminescent compounds |
| 03/27/2008 | US20080075973 Red Electroluminescent Compounds And Organic Electroluminescent Device Using The Same |
| 03/27/2008 | US20080074045 Organic electroluminescence device |
| 03/27/2008 | DE102006043443A1 Neue aza-bicyclische Verbindungen und ihre Verwendung New aza-bicyclic compounds and their use |
| 03/27/2008 | CA2666649A1 Insulin resistance improving agent |
| 03/27/2008 | CA2664040A1 Fluorinated catharanthine derivatives, their preparation and their utilisation as vinca dimeric alkaloid precursors |
| 03/27/2008 | CA2662848A1 2-aryl-6-phenylimidazo[1,2-.alpha.]pyridine derivatives, preparation thereof and therapeutic use thereof |
| 03/26/2008 | EP1902055A1 Pyridazine compounds as glycogen synthase kinase 3 inhibitors |
| 03/26/2008 | EP1902054A1 Derivatives of pyrido[2,3-d]pyrimidine, the preparation thereof and the therapeutic application of the same |
| 03/26/2008 | EP1902050A1 Oxazolidinone derivatives and use thereof as antibiotics |
| 03/26/2008 | EP1902046A1 Piperidine derivatives useful as histamine h3 antagonists |
| 03/26/2008 | EP1778685B1 Indolizine carboxamides and the aza and diaza derivatives thereof |
| 03/26/2008 | EP1725567B1 Spirocyclic cyclohexane derivatives with affinity to the orl-1 receptor |
| 03/26/2008 | EP1633716A4 Biarylmethyl indolines, indoles and tetrahydroquinolines, useful as serine protease inhibitors |